Stress-activated kinase pathway alteration is a frequent event in bladder cancer

scientific article

Stress-activated kinase pathway alteration is a frequent event in bladder cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.UROLONC.2010.03.002
P8608Fatcat IDrelease_36qxb25jvbbw7eysj5adkjuabq
P698PubMed publication ID22154358

P2093author name stringVictoria L Robinson
Kristen B Otto
Sujeet S Acharya
P2860cites workIndependent human MAP-kinase signal transduction pathways defined by MEK and MKK isoformsQ24312029
Characterization of the structure and function of a novel MAP kinase kinase (MKK6)Q24336966
Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinaseQ24655723
Cancer statistics, 2008Q27860585
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functionsQ29547189
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammationQ29614227
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancerQ33247062
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladderQ33317632
Generation of a concise gene panel for outcome prediction in urinary bladder cancerQ33561596
Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinaseQ34462888
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Q36341182
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cellsQ38498843
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activityQ39752793
Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.Q40048075
Differential susceptibility to TRAIL of normal versus malignant human urothelial cells.Q40330291
Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.Q40473062
Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strengthQ40852104
Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell linesQ46976418
P433issue4
P304page(s)415-420
P577publication date2011-12-11
P1433published inUrologic OncologyQ2113446
P1476titleStress-activated kinase pathway alteration is a frequent event in bladder cancer
P478volume30

Reverse relations

cites work (P2860)
Q47386000Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer.
Q40468889Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
Q40745717Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.
Q34685436Multiple mechanisms mediate resistance to sorafenib in urothelial cancer
Q60601167Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration
Q36265434The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

Search more.